NCT00505986

Brief Summary

Determine if different genomic endometrial expression exists during embryo implantation in obese women in comparison with non obese women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jun 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 25, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

April 2, 2012

Status Verified

March 1, 2012

Enrollment Period

1.9 years

First QC Date

July 23, 2007

Last Update Submit

March 30, 2012

Conditions

Obesity and Embryo Implantation

Interventions

endometrial biopsyPROCEDURE

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • group A: non obese oocyte donors (BMI: 18 - 29 kg. /m2)with proven fertility
  • group B: obese oocyte donors: (BMI: \>29 kg./m2)with proven fertility
  • group C: obese (BMI: \>29 kg./m2) infertile patients,

You may not qualify if:

  • recurrent miscarriage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Valenciano de Infertilidad Spain

Valencia, Valencia, 46015, Spain

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jose Bellver, MD PhD

    Instituto Valenciano de Infertilidad

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gynecologist IVI Valencia

Study Record Dates

First Submitted

July 23, 2007

First Posted

July 25, 2007

Study Start

June 1, 2007

Primary Completion

May 1, 2009

Study Completion

May 1, 2009

Last Updated

April 2, 2012

Record last verified: 2012-03

Locations

ES(1)